Viewing Study NCT02507232


Ignite Creation Date: 2025-12-24 @ 9:54 PM
Ignite Modification Date: 2026-02-22 @ 4:52 PM
Study NCT ID: NCT02507232
Status: TERMINATED
Last Update Posted: 2020-07-28
First Post: 2015-07-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of NovoTTF-200A Alone and With Temozolomide in Patients With Low-Grade Gliomas
Sponsor: Santosh Kesari
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: JWCI-16-1101
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View